uniQure N.V. Ordinary Shares vs Veralto Corp Common Stock — how do they compare? uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B), while Veralto Corp Common Stock trades at $100.6 (market cap $24.13B). The key difference: Veralto Corp Common Stock is far larger — about 16.3× uniQure N.V. Ordinary Shares's market cap, and Veralto Corp Common Stock pays a 0.53% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Veralto Corp Common Stock for 0 Days on average.
| QURE | VLTO | |
|---|---|---|
Market Cap | $1.48B | $24.13B |
Volume | 2,488,780 | 1,906,414 |
Sector | Health | Industrials |
52-Week High | $70.59 | $104.87 |
52-Week Low | $9.03 | $82.23 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $728.62M | $25.39B |
Dividend Yield | — | 0.53% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →Veralto Corporation provides water quality and product quality technologies through two segments, Water Quality and Product Quality & Innovation. Its offerings include water analytics and treatment instruments, marking and coding equipment for packaging, and color measurement solutions such as X-Rite.
Read more on VLTO →